#United States #Santa Clara #NeedleVue #DeepSight #Ultrasound

DeepSight™ Technology Introduces NeedleVue™ LiteCart at RSNA 2024

DeepSight™ Technology, Inc., a frontrunner in medical imaging advancements, is excited to showcase its investigational NeedleVue™ LiteCart Ultrasound System at the upcoming Radiological Society of North America (RSNA) conference, scheduled from December 1 to 4, 2024. This unveiling represents a significant stride towards improving ultrasound-guided interventional procedures, an area where many clinicians face challenges.

The NeedleVue system aims to transform how healthcare professionals perceive and execute interventional procedures by providing unparalleled clarity and reliability in visualizing needles, guidewires, and catheters. This innovative device eliminates the complexities associated with traditional methodologies, promising to fetch real-time ultrasound visualization without any radiation exposure or the need for cumbersome calibration protocols.

Nader Sadrzadeh, the Co-Founder and CEO of DeepSight Technology, expressed enthusiasm for the technology's potential, stating, "The possible applications for NeedleVue technology are infinite, and it stands as a beacon for overcoming existing limitations while representing the future of ultrasound-guided interventional procedures."

Key Features of NeedleVue™ LiteCart

The NeedleVue LiteCart is engineered to enhance precision and boost confidence in ultrasound-guided medical procedures. A notable attribute of this system is the incorporation of tiny sensors located at the tip of needles, stylets, introducers, and catheters. This intuitive design eliminates the need for intricate setups, enabling a free-hand workflow that is user-friendly and accessible to a wide variety of clinicians.

The technology represents an entirely inert and non-electrical solution, assuring performance regardless of external conditions such as temperature or magnetic fields. This makes the NeedleVue particularly adaptable to various medical environments. The primary intended application of the system is for abdominal ultrasound-guided procedures, focusing especially on biopsies.

Furthermore, the system's capabilities extend to operating efficiently in scenarios where contrast agents are involved. With omnidirectional sensing functions, NeedleVue is meticulously designed to deliver comprehensive imaging visibility regardless of the instrument’s angle, thus ensuring that users have all the necessary information at their disposal without compromising safety or quality.

Join Us at RSNA 2024

DeepSight™ Technology cordially invites interested clinical investigators and collaborators to visit their booth (6306) located in the North Hall of McCormick Place during RSNA 2024. Attendees can look forward to a special presentation scheduled for December 2nd at 2 PM in the Innovation Theater, led by Dr. Jennifer Young, an Interventional Radiologist. She will delve into the potential future clinical studies surrounding the NeedleVue technology, providing further insights into its transformative capabilities.

For those seeking more information or looking to discuss possible research collaborations, inquiries can be directed to Heike Seck via email.

About DeepSight™ Technology

Established in 2019, DeepSight Technology is committed to redefining medical ultrasound through advanced imaging technology and innovative interventional solutions. Their proprietary sensor technology aims to surpass the traditional capabilities of conventional piezoelectric sensors, setting a new standard for ultrasound imaging in the future. Currently, the NeedleVue device is not approved by the U.S. Food and Drug Administration (FDA) and is not available for commercial sale within the U.S. As the first application focuses on ultrasound-guided biopsies, the potential to expand into a variety of medical specialties appears boundless. For more details about the company, please visit DeepSight's website.

Caution: The NeedleVue device is an investigational product, restricted by U.S. law to research use only. NeedleVue and DeepSight are trademarks of DeepSight Technology, Inc.